Matignon Technologies
9
7M
7
3
0.22
1
- Stages of investment
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Paris. The venture was found in Europe in France.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Matignon Technologies, startups are often financed by Societe Generale Asset Management, MDS Capital, Charleston Angel Partners. The meaningful sponsors for the fund in investment in the same round are Societe Generale Asset Management, MDS Capital, MB Venture Partners. In the next rounds fund is usually obtained by Ridgeback Capital, Kensey Nash Corporation, InnoBio Fund.
Among the most popular fund investment industries, there are Manufacturing, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the various public portfolio startups of the fund, we may underline Orteq, Arterial Remodeling Technologies Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2007. Comparing to the other companies, this Matignon Technologies performs on 4 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 3
- Exits
- 1
- Follow on index
- 0.22
- Investments by industry
- Biotechnology (7)
- Health Care (6)
- Medical Device (5)
- Manufacturing (4)
- Medical (3) Show 4 more
- Investments by region
-
- France (4)
- United States (3)
- United Kingdom (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Nanobiotix | 05 May 2010 | Biotechnology, Health Care, Therapeutics | Late Stage Venture | 8M | Ile-de-France, Paris, France |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.